Raymond James Financial Inc. Purchases Shares of 390,554 Core Laboratories Inc. (NYSE:CLB)

Raymond James Financial Inc. acquired a new stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 390,554 shares of the oil and gas company's stock, valued at approximately $6,760,000. Raymond James Financial Inc. owned approximately 0.83% of Core Laboratories at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the business. Geode Capital Management LLC increased its stake in shares of Core Laboratories by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 1,058,620 shares of the oil and gas company's stock valued at $18,329,000 after buying an additional 5,416 shares during the period. Boston Trust Walden Corp grew its stake in shares of Core Laboratories by 2.7% in the 4th quarter. Boston Trust Walden Corp now owns 617,336 shares of the oil and gas company's stock valued at $10,686,000 after buying an additional 16,503 shares during the period. Van ECK Associates Corp raised its stake in Core Laboratories by 6.3% during the 4th quarter. Van ECK Associates Corp now owns 443,621 shares of the oil and gas company's stock worth $7,679,000 after buying an additional 26,237 shares during the period. Principal Financial Group Inc. grew its stake in Core Laboratories by 3.1% in the fourth quarter. Principal Financial Group Inc. now owns 229,096 shares of the oil and gas company's stock valued at $3,966,000 after acquiring an additional 6,827 shares during the period. Finally, Russell Investments Group Ltd. increased its holdings in shares of Core Laboratories by 27.4% during the fourth quarter. Russell Investments Group Ltd. now owns 212,823 shares of the oil and gas company's stock valued at $3,684,000 after acquiring an additional 45,739 shares in the last quarter. 97.81% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on CLB. Citigroup upgraded shares of Core Laboratories from a "sell" rating to a "neutral" rating and upped their target price for the stock from $15.00 to $16.00 in a research note on Wednesday, March 12th. StockNews.com lowered Core Laboratories from a "hold" rating to a "sell" rating in a report on Friday. Finally, Stifel Nicolaus reduced their price target on shares of Core Laboratories from $19.00 to $15.00 and set a "hold" rating for the company in a research report on Tuesday, April 15th. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $15.75.

Core Laboratories Stock Up 0.8 %

Shares of NYSE CLB traded up $0.09 during trading on Tuesday, reaching $11.39. The company had a trading volume of 66,978 shares, compared to its average volume of 411,391. The business's 50-day moving average is $13.87 and its 200 day moving average is $17.11. The company has a quick ratio of 1.71, a current ratio of 2.32 and a debt-to-equity ratio of 0.49. The stock has a market cap of $531.94 million, a PE ratio of 17.25, a P/E/G ratio of 0.99 and a beta of 1.99. Core Laboratories Inc. has a 12-month low of $10.14 and a 12-month high of $25.13.

Core Laboratories (NYSE:CLB - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). The company had revenue of $123.59 million for the quarter, compared to the consensus estimate of $125.09 million. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. The firm's revenue for the quarter was down 4.7% on a year-over-year basis. During the same quarter last year, the company earned $0.19 EPS. As a group, equities analysts forecast that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year.

Core Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Shareholders of record on Monday, May 5th will be issued a $0.01 dividend. The ex-dividend date of this dividend is Monday, May 5th. This represents a $0.04 dividend on an annualized basis and a yield of 0.35%. Core Laboratories's dividend payout ratio is currently 6.78%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.